Tricuspid regurgitation is a complex disease that carries a poor prognosis, and surgical repair is associated with high mortality. In light of the success of other transcatheter-based valve interventions, transcatheter tricuspid therapy has recently seen exponential use both clinically and in innovation. Given the rapid development of many tricuspid systems and multiple on-going clinical trials, the aim of this review is to highlight the current state of transcatheter tricuspid therapeutics and to provide an up-to-date view of their clinical use, outcomes and future directions.
Keywords: Atrial fibrillation; pacemaker; right ventricular failure; transcatheter therapies; transcatheter tricuspid intervention; tricuspid annuloplasty; tricuspid regurgitation; tricuspid replacement; tricuspid valve; tricuspid valve annular dilation.
© Touch Medical Media 2022.